AC
CNK icon

Aperimus Capital’s Cinemark Holdings CNK Stock Holding History

Aperimus Capital’s Portfolio CNK Stock Details CNK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$606K Buy
+27,600
New +$612K 0.97% 18

Other funds holding CNK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Aperimus Capital's CNK Position: Q2 2021 in Review

Aperimus Capital opened a new position in Cinemark Holdings (CNK) in Q2 2021: 27,600 shares worth $606K. The stake represents 0.97% of the portfolio and ranks #18 among its holdings.

260 funds tracked by Wall St. Rank hold CNK as of Q2 2021.

  • Aperimus Capital held 27,600 shares of Cinemark Holdings worth $606K as of Q2 2021.
  • Cinemark Holdings was a new Aperimus Capital position in Q2 2021.
  • Cinemark Holdings made up 0.97% of Aperimus Capital's portfolio in Q2 2021, its #18 holding.
  • 260 funds tracked by Wall St. Rank held Cinemark Holdings as of Q2 2021.

Based on Aperimus Capital's 13F filing for Q2 2021, filed 28 Jul 2021.